The following articles (labelled with PubMed ID or TBD) are for your review
||5,6,7-trisubstituted 4-aminopyrido[2,3-d]pyrimidines as novel inhibitors of adenosine kinase.
||Design, synthesis, and structure-activity relationship of 6-alkynylpyrimidines as potent adenosine kinase inhibitors.
||Synthesis and biological evaluation of clitocine analogues as adenosine kinase inhibitors.
||Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitor..
||Structure-activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitors.
||N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties.
||Pudue Pharma Discovery Research
||Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
||University of North Carolina
||Crystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes.